Skip to main content

HTG Molecular Diagnostics, Inc

HTGMDelisted Jul 10, 2023
Industry
Laboratory Analytical Instruments
SEC CIK
0001169987

HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding HTG Molecular Diagnostics, Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of HTGM: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders2325+2
Shares2.12M3.40M+1.28M (+60.1%)
Value$11.2M$19.7M+$8.58M (+76.8%)

New holders (5)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to HTGM in Q2 2021
InstitutionSharesValue% of portfolio
Cowen Prime Advisors LLC570,333$3.31M1.20%
PDT Partners, LLC15,501$90.0K0.01%
State Street Corp14,043$82.0K0.00%
Advisory Services Network, LLC3,700$21.0K0.00%
Sonora Investment Management, LLC466$3.00K0.00%

Sold out (3)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of HTGM in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Citadel Advisors LLC18,812$103.0K
Tower Research Capital LLC (TRC)10,871$59.0K
Bank of America Corp19$0